S.J. Cooper

460 total citations
21 papers, 244 citations indexed

About

S.J. Cooper is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, S.J. Cooper has authored 21 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in S.J. Cooper's work include Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (5 papers) and Treatment of Major Depression (5 papers). S.J. Cooper is often cited by papers focused on Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (5 papers) and Treatment of Major Depression (5 papers). S.J. Cooper collaborates with scholars based in United Kingdom, Denmark and Canada. S.J. Cooper's co-authors include K A Brown, James Semple, R.J. Rodgers, Daniel Griffiths-King, Gavin P. Reynolds, R.W. Bell, Marie Cahir, Malcolm Peet, Supratik Basu and Anthony W. Rowbottom and has published in prestigious journals such as Biological Psychiatry, Cochrane Database of Systematic Reviews and The British Journal of Psychiatry.

In The Last Decade

S.J. Cooper

21 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.J. Cooper United Kingdom 9 91 55 54 53 32 21 244
Uma Suryadevara United States 9 74 0.8× 32 0.6× 26 0.5× 40 0.8× 25 0.8× 14 221
Chris Ware United Kingdom 12 87 1.0× 156 2.8× 142 2.6× 91 1.7× 6 0.2× 14 518
Barbara Hoefgen Germany 7 70 0.8× 154 2.8× 114 2.1× 39 0.7× 5 0.2× 7 383
Omri Teltsh Israel 8 44 0.5× 62 1.1× 26 0.5× 27 0.5× 10 0.3× 14 246
Atsuomi Baba Japan 13 83 0.9× 111 2.0× 154 2.9× 29 0.5× 4 0.1× 26 335
G.‐C. Yeh Taiwan 9 85 0.9× 157 2.9× 174 3.2× 28 0.5× 17 0.5× 14 353
Qiaoyan Hu United States 11 116 1.3× 118 2.1× 31 0.6× 24 0.5× 4 0.1× 21 382
Dong Tran United States 8 101 1.1× 187 3.4× 46 0.9× 30 0.6× 4 0.1× 12 498
Hans‐Hermann Klünemann Germany 9 117 1.3× 48 0.9× 29 0.5× 13 0.2× 72 2.3× 13 382
B. Mercier France 6 155 1.7× 27 0.5× 65 1.2× 41 0.8× 3 0.1× 8 428

Countries citing papers authored by S.J. Cooper

Since Specialization
Citations

This map shows the geographic impact of S.J. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.J. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.J. Cooper more than expected).

Fields of papers citing papers by S.J. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.J. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.J. Cooper. The network helps show where S.J. Cooper may publish in the future.

Co-authorship network of co-authors of S.J. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of S.J. Cooper. A scholar is included among the top collaborators of S.J. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.J. Cooper. S.J. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowbottom, Anthony W., et al.. (2013). A multicentre study comparing two methods for serum free light chain analysis. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 50(3). 255–261. 44 indexed citations
2.
Cahir, Marie, et al.. (2008). Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain. Journal of Psychopharmacology. 23(1). 51–55. 32 indexed citations
3.
Morris, Shaunna, et al.. (2000). Zotepine for schizophrenia. Cochrane Database of Systematic Reviews. CD001948–CD001948. 6 indexed citations
4.
Cooper, S.J., et al.. (2000). Zotepine is effective in preventing recurrence in patients with chronic schizophrenia. Schizophrenia Research. 41(1). 207–208. 7 indexed citations
5.
Griffiths-King, Daniel, et al.. (1998). A randomised controlled trial of sertraline for depressive symptoms in stable, chronic schizophrenia. Schizophrenia Research. 29(1-2). 153–154. 1 indexed citations
6.
Cooper, S.J., et al.. (1998). Zotepine is effective in preventing recurrence in patients with chronic schizophrenia. European Neuropsychopharmacology. 8. S232–S232. 4 indexed citations
7.
Cooper, S.J., et al.. (1997). Zotepine in the prevention of relapse. Biological Psychiatry. 42(1). 41S–41S. 6 indexed citations
8.
Cooper, S.J., et al.. (1997). P.2.105 Zotepine in the treatment of chronic schizophrenia. European Neuropsychopharmacology. 7. S225–S225. 1 indexed citations
9.
Cooper, S.J., et al.. (1996). Zotepine in acute exacerbation of schizophrenia: A comparison versus chlorpromazine and placebo. European Neuropsychopharmacology. 6. 148–148. 8 indexed citations
10.
Cooper, S.J., et al.. (1994). A-68930, a novel, potent dopamine D1 receptor agonist: a microstructural analysis of its effects on feeding and other behaviour in the rat.. PubMed. 5(2). 210–218. 19 indexed citations
11.
Dourish, Colin T., John Francis, & S.J. Cooper. (1992). Mechanistic studies of CCK/5-HT interactions in the control of feeding and gastric emptying in rats. Appetite. 19(2). 174–174. 1 indexed citations
12.
Cooper, S.J., et al.. (1991). Toxic elevation of serum lithium concentration by non-steroidal anti-inflammatory drugs.. PubMed. 60(2). 240–2. 4 indexed citations
13.
Cooper, S.J., et al.. (1988). The Effect of Electroconvulsive Therapy on CSF Amine Metabolites in Schizophrenic Patients. The British Journal of Psychiatry. 152(1). 59–63. 11 indexed citations
14.
King, Doug, et al.. (1987). Rapid Normalization of the Dexamethasone Suppression Test with Mianserin. International Clinical Psychopharmacology. 2(2). 111–116. 3 indexed citations
15.
Cooper, S.J., et al.. (1984). Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium.. British Journal of Clinical Pharmacology. 18(1). 21–25. 2 indexed citations
16.
King, DJ, S.J. Cooper, & Jennifer Liddle. (1983). The effect of propranolol on CSF amine metabolites in psychiatric patients.. British Journal of Clinical Pharmacology. 15(3). 331–337. 8 indexed citations
17.
Peet, Malcolm, et al.. (1981). Propranolol in Schizophrenia. The British Journal of Psychiatry. 139(2). 105–111. 34 indexed citations
18.
Cooper, S.J. & K. F. Sweeney. (1979). Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].. PubMed. 66(1). 147P–148P. 3 indexed citations
19.
Rodgers, R.J., James Semple, S.J. Cooper, & K A Brown. (1976). Shock-induced aggression and pain sensitivity in the rat: Catecholamine involvement in the corticomedial amygdala. Aggressive Behavior. 2(3). 193–204. 38 indexed citations
20.
Brown, K A & S.J. Cooper. (1975). Proceedings: Effects of lysergic acid diethylamide on auditory and visual discrimination in the rat.. PubMed. 54(2). 234P–234P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026